Amgen Inc.

AMGN
Healthcare
$447.33
2.22%Overvalued

Amgen Inc. (AMGN) is a Healthcare company that currently yields 2.22% — historically overvalued based on 10 years of dividend yield history. The Weiss valuation model places the undervaluation threshold at $269.59 and the overvaluation threshold at $348.08. Amgen Inc. holds a quality score of 62/100 (Good), reflecting 13 consecutive years of dividend growth with a 58% payout ratio. The 5-year dividend CAGR stands at 8.3%.

AMGN Dividend Yield History — Weiss Valuation

Underval. $269.59Overval. $348.08

Distance to undervalued

Entry price is stretched

Needs 39.7% downside to reach the Weiss buy zone

Undervaluation starts near $269.59, where the annual dividend would imply roughly 3.69% yield. That is 1.46% above today's yield.

Buy-zone price

$269.59

Target yield

3.69%

Research checklist

What to clear before buying the yield

Updated Nov 18, 2026

Dividend durability

14Y

Long dividend history supports a deeper look.

Earnings payout

58%

Earnings coverage leaves room for noise.

Cash payout

74%

Free cash flow coverage supports the payment.

Dividend growth

8.3%

Recent growth adds income compounding potential.

What changed

What changed since the last update

2026-11-17 → 2026-11-18

Price

-2.0%

$456.56 → $447.33

Price fell 2.0% since the prior snapshot.

Why Now?

Amgen Inc. is trading near its historical overvaluation band.

Current yield 2.2% vs historical max 3.6% (62% of maximum).

14 consecutive years without a dividend cut.

Conservative payout ratio of 58%.

What matters now

Read the signal before the headline yield

Valuation is the brake here: the yield is compressed versus its own history.

The 62/100 quality score calls for selective follow-up, not autopilot.

Start by checking whether payout coverage and business durability still support the dividend.

AMGN Dividend Income Projection — DRIP Compounder

Dividend Compounder (DRIP)

$

Year 1 Income

$241

Year 10 Income

$665

Yield on Cost

6.98%

Total Income

$4,151

Assumes dividends reinvested at current price. Simplified model — for illustrative purposes only.

Track actual vs. projected

See what AMGN dividends you actually received with Sharesight

Dividend income log · Yield on cost · DRIP cost basis · Tax reports

→

More research

Full price history & technical analysis

TradingView ↗

Fundamentals, valuation & analyst ratings

FinViz ↗

Moat rating & analyst fair value

Morningstar ↗

Track dividends received & tax reports

Sharesight ↗

AMGN Dividend Quality Score

Quality Score

62/ 100

Good

Payout Ratio12/25
Dividend Streak20/25
Growth (CAGR 5Y)20/20
Yield vs History5/15
FCF Coverage5/15

Key Metrics

Current Price$447.33
Annual Dividend$9.94
Current Yield2.22%
Yield — Max (10Y)3.61%
Yield — Min (10Y)2.30%
Undervalued Below$269.59
Overvalued Above$348.08
Payout Ratio57.62%
CAGR Dividend 5Y8.3%
CAGR Dividend 10Y11.7%
Years No Cut14y

Invest in AMGN

Check Amgen Inc. availability and current costs on eToro

Check eToro terms and availability →
Fractional sharesFees vary by countryCapital at risk

DividendVisual may earn a commission if you open an account via this link, at no cost to you. Capital at risk. Not financial advice.

13
consecutive years of dividend growth